argenx SE (ARGX) PT Raised to $707 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. LMT
10. SBUX

Go back to argenx SE (ARGX) PT Raised to $707 at Jefferies

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

November 20, 2024 1:00 AM EST


Phase 2 data establish proof-of-concept of efgartigimod SC in myositis

Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIA

Potential for efgartigimod SC to be first targeted approach for myositis patients who have limited treatment options

November 20, 2024, 7:00 AM CET

Amsterdam, the Netherlands argenx... More